209696 - A targeted safety study, EPI-ZOSTER-032 VS US DB, to evaluate the safety of Shingrix in adults ≥ 65 years of age in the United States.

11/09/2020
29/07/2026
EU PAS number:
EUPAS37133
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Redacted EPI-ZOSTER-032 Protocol Amendment 3 Anonymized 16 Aug 2022

English (914.29 KB - PDF) View document
Study results
Study report
Abstract of study report

Abstract-Anonymised 10 Jul 2026.pdf

English (131.5 KB - PDF) View document
Study report

Clinical Study Report Body-Anonymised 10 Jul 2026.pdf

English (13.94 MB - PDF) View document
Other information